injectable News and Resources

PharmaScience, the Canadian-owned pharmaceutical company, has announced a significant expansion of its Contract Development and Manufacturing Organisation (CDMO) services. This expansion follows the company’s recent $120 million sterile injectable manufacturing facility expansion at its Canadian site. The company has created a